Fertin Pharma is preparing for a period of heightened prosperity by investing in new facilities , as it anticipates a rise in individuals who attempt to cease using cigarettes and other tobacco products .

Most recently it has invested in a nicotine science centre at its headquarters in Vejle , Denmark , which also houses a research and development laboratory ( R & D ), quality assurance centre and new packaging facilities alongside the manufacturing plant . An R & D centre has been built at its division in Mumbai , India too .

This is part of a strategic planning process for the 100-year old firm which it intends to act as a foundation for future company growth , as much of Asia tightens its tobacco regulations and smoking cessation seemingly becomes an ever popular notion in what is now

50 March 2015

Business Chief Europe Magazine March 2015 | Page 50

The world leader in the development and manufacturing of medicated chewing gum has been investing in various business areas in anticipation of a rise in smoking cessation participants

Fertin Pharma is preparing for a period of heightened prosperity by investing in new facilities , as it anticipates a rise in individuals who attempt to cease using cigarettes and other tobacco products .